Slingshot members are tracking this event:

Cytokinetics expect to complete target enrollment of 600 patients in VITALITY-ALS in the first half of 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CYTK Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 17, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Vitality-als, Tirasemtiv, Als Disease, Amyotrophic Lateral Sclerosis, Slow Vital Capacity